NCT01619189View on ClinicalTrials.gov

Cell Therapy in Failure Syndromes in Limbal Stem Cells

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

March 6, 2017

Study Completion Date

March 6, 2017

Conditions
Limbal Deficiency
Interventions
BIOLOGICAL

epithelial stem cells cultured

transplantation of allogeneic or autologous limbal epithelial stem cells cultured on human amniotic membrane with no feeders

PROCEDURE

transplantation of cultured cells

transplantation of allogeneic or autologous limbal epithelial stem cells cultured on human amniotic membrane with no feeders

Trial Locations (1)

75012

CHNO des quinze-vingts, Paris

All Listed Sponsors
collaborator

Etablissement Français du Sang

OTHER

lead

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

OTHER

NCT01619189 - Cell Therapy in Failure Syndromes in Limbal Stem Cells | Biotech Hunter | Biotech Hunter